Suchergebnisse - "Kidney/drug effects"

  1. 1
  2. 2
  3. 3
  4. 4

    Quelle: Cancer Chemother Pharmacol
    Cancer Chemotherapy and Pharmacology, 94, 6, pp. 799-806

  5. 5
  6. 6

    Quelle: Ravn-Nielsen, L V, Andersen, T R H, Olesen, C, Hedegaard, U, Coric, F, Routhe, L G, Revell, J H P, Press, A B G, Houlind, M B & Kjeldsen, L J 2024, ' Development of a quick guide for assessment of the most frequently used renal risk medication in Danish hospitals and primary care ', Basic and Clinical Pharmacology and Toxicology, vol. 135, no. 4, pp. 491-498 . https://doi.org/10.1111/bcpt.14068

    Dateibeschreibung: application/pdf

  7. 7

    Quelle: Clin Exp Nephrol

  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Quelle: Cardiovasc Diabetol
    Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)

    Schlagwörter: Male, Time Factors, Linagliptin, Pulse Wave Analysis, Kidney, 03 medical and health sciences, Vascular Stiffness, 0302 clinical medicine, Glucosides, Diseases of the circulatory (Cardiovascular) system, Humans, Insulin, Diabetic Nephropathies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, PWV, Research, Middle Aged, Metformin, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, GFR decline, Female, Drug Therapy, Combination, Benzhydryl Compounds/therapeutic use [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Diabetes Mellitus, Type 2/physiopathology [MeSH], Sodium-Glucose Transporter 2 [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Metformin/therapeutic use [MeSH], Kidney/physiopathology [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Clinical Relevance [MeSH], Drug Therapy, Combination [MeSH], SGLT2 inhibitors, Glomerular Filtration Rate/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Insulin [MeSH], Linagliptin/adverse effects [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Diabetic Nephropathies/drug therapy [MeSH], Pulse Wave Analysis [MeSH], Vascular Stiffness/drug effects [MeSH], Glomerular Filtration Rate

  13. 13

    Weitere Verfasser: Hammer, Nathalie Hoessly, Linard Haidar, Fadi et al.

    Quelle: Transpl Int
    Transplant International, Vol 37 (2024)
    Hammer, Nathalie; Hoessly, Linard; Haidar, Fadi; Hirzel, Cédric; de Seigneux, Sophie; van Delden, Christian; Vogt, Bruno; Sidler, Daniel; Neofytos, Dionysios (2024). Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients. Transplant international, 37 Frontiers 10.3389/ti.2024.12712 <http://dx.doi.org/10.3389/ti.2024.12712>
    Hammer, Nathalie; Hoessly, Linard; Haidar, Fadi; Hirzel, Cédric; de Seigneux, Sophie; van Delden, Christian; Vogt, Bruno; Sidler, Daniel; Neofytos, Dionysios (2024). Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients. Transplant international, 37, p. 12712. Frontiers 10.3389/ti.2024.12712 <http://dx.doi.org/10.3389/ti.2024.12712>

    Dateibeschreibung: application/pdf

  14. 14

    Quelle: Cardiovasc Diabetol
    Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-14 (2024)
    Cardiovascular Diabetology

    Schlagwörter: Research, Novel Cardioprotective Antidiabetic Medications, Pharmacometabolomics, Metformin, SGLT2 inhibitors, TCA cycle, Anaplerosis, Anti-inflammatory effects, Metabolic dysfunction-associated steatotic liver disease (MASLD), Type 2 diabetes, Male, Blood Glucose, 0301 basic medicine, Citric Acid Cycle, Kidney, Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Hypoglycemic Agents/pharmacology [MeSH], Mice, Inbred C57BL [MeSH], Aged [MeSH], Liver/metabolism [MeSH], Liver/drug effects [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Male [MeSH], Drug Therapy, Combination [MeSH], Citric Acid Cycle/drug effects [MeSH], Female [MeSH], Biomarkers/blood [MeSH], Kidney/metabolism [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Longitudinal Studies [MeSH], Middle Aged [MeSH], Animals [MeSH], Diabetes Mellitus, Type 2/blood [MeSH], Metabolomics [MeSH], Mice [MeSH], Blood Glucose/metabolism [MeSH], Sodium-Glucose Transporter 2 Inhibitors/pharmacology [MeSH], Diabetes Mellitus, Type 2/metabolism [MeSH], Blood Glucose/drug effects [MeSH], Metformin/pharmacology [MeSH], Mice, 03 medical and health sciences, Diseases of the circulatory (Cardiovascular) system, Animals, Humans, Hypoglycemic Agents, Metabolomics, Longitudinal Studies, Sodium-Glucose Transporter 2 Inhibitors, Aged, ddc:610, 0303 health sciences, Middle Aged, ddc, 3. Good health, Mice, Inbred C57BL, Diabetes Mellitus, Type 2, Liver, RC666-701, Female, Drug Therapy, Combination, Biomarkers

    Dateibeschreibung: application/pdf

  15. 15
  16. 16

    Quelle: Baekelandt, S, Cornet, V, Mandiki, R, Lambert, J, Dubois, M & Kestemont, P 2021, 'Ex vivo approach supports both direct and indirect actions of melatonin on immunity in pike-perch Sander lucioperca', Fish & Shellfish Immunology, vol. 112, pp. 143-150. https://doi.org/10.1016/j.fsi.2021.03.005

    Dateibeschreibung: application/pdf

  17. 17

    Quelle: Kidney & Blood Pressure Research, Vol 46, Iss 3, Pp 331-341 (2021)

    Dateibeschreibung: application/pdf

  18. 18

    Quelle: DAPA-CKD Trial Committees and Investigators 2021, ' Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease : a prespecified analysis from the DAPA-CKD trial ', The Lancet Diabetes and Endocrinology, vol. 9, no. 1, pp. 22-31 . https://doi.org/10.1016/S2213-8587(20)30369-7

    Dateibeschreibung: application/pdf

  19. 19

    Quelle: J Acquir Immune Defic Syndr

    Dateibeschreibung: image/pdf

  20. 20

    Quelle: Pflugers Arch

    Dateibeschreibung: application/pdf